Soru

Zorluk: Çok zorRheumatology and Immunology

A 2626-year-old female patient is evaluated in the intensive care unit on postoperative day 44 following a right total hip arthroplasty. Her past medical history is significant for Adult-Onset Still's disease, for which she is chronically managed with methotrexate and tocilizumab. She has developed acute lethargy, confusion, and a temperature of 39.9∘C39.9^\circ\text{C} (103.8∘F103.8^\circ\text{F}).

Physical examination reveals a blood pressure of 90/55 mmHg90/55 \text{ mmHg}, heart rate of 132/min132/\text{min}, and respiratory rate of 26/min26/\text{min}. The surgical incision is clean, dry, and without erythema or fluctuance. Pulmonary and cardiac examinations are unremarkable. Abdominal examination reveals hepatosplenomegaly.

Laboratory studies are as follows:

ParameterResultReference Range
Hemoglobin7.8 g/dL7.8 \text{ g/dL}12.0−16.0 g/dL12.0-16.0 \text{ g/dL}
Leukocytes1,200/mm31,200/\text{mm}^34,000−11,000/mm34,000-11,000/\text{mm}^3
Platelets45,000/mm345,000/\text{mm}^3150,000−400,000/mm3150,000-400,000/\text{mm}^3
Aspartate aminotransferase (AST)850 U/L850 \text{ U/L}8−20 U/L8-20 \text{ U/L}
Alanine aminotransferase (ALT)790 U/L790 \text{ U/L}8−20 U/L8-20 \text{ U/L}
Serum ferritin22,000 ng/mL22,000 \text{ ng/mL}15−200 ng/mL15-200 \text{ ng/mL}
Fibrinogen85 mg/dL85 \text{ mg/dL}200−400 mg/dL200-400 \text{ mg/dL}
Thyroid-stimulating hormone (TSH)0.8 \muU/mL0.8 \text{ \mu U/mL}0.4−4.0 \muU/mL0.4-4.0 \text{ \mu U/mL}
Free T40.5 ng/dL0.5 \text{ ng/dL}0.9−1.7 ng/dL0.9-1.7 \text{ ng/dL}

Arterial blood gas (room air) shows pH\text{pH} 7.527.52, pCO2\text{pCO}_2 26 mmHg26 \text{ mmHg}, pO2\text{pO}_2 88 mmHg88 \text{ mmHg}, and HCO3−\text{HCO}_3^- 21 mEq/L21 \text{ mEq/L}.

Which of the following is the most appropriate next step in the management of this patient?

  1. A
    Surgical exploration and debridement of the right hip
  2. B
    Initiation of broad-spectrum antibacterial therapy
  3. C
    Intravenous levothyroxine and hydrocortisone
  4. High-dose intravenous methylprednisoloneCevap
  5. E
    Intravenous sodium bicarbonate infusion

Cevap

High-dose intravenous methylprednisolone
The correct answer identifies the need for immediate immunosuppression to treat Macrophage Activation Syndrome (MAS). MAS is a secondary form of hemophagocytic lymphohistiocytosis (HLH) most commonly seen in patients with Adult-Onset Still's disease (AOSD) or systemic juvenile idiopathic arthritis. It is characterized by uncontrolled activation of macrophages and T lymphocytes, leading to a massive cytokine storm. The classic presentation includes unremitting high fever, hepatosplenomegaly, profound cytopenias, transaminitis, and coagulopathy. A markedly elevated serum ferritin (often >10,000 ng/mL) and hypofibrinogenemia are diagnostic hallmarks that help differentiate MAS from severe sepsis or a standard disease flare. Because the mortality rate is exceptionally high without treatment, the rapid initiation of high-dose corticosteroids (e.g., intravenous methylprednisolone) is the critical next step to halt the hyperinflammatory cascade.

Adım Adım Çözüm

1
Analyze the clinical presentation and timing.
The patient has unremitting fever, hepatosplenomegaly, and shock on postoperative day 4 following major surgery.
To establish the acute differential diagnosis for systemic collapse in a surgical patient.
2
Evaluate the laboratory data for specific patterns.
Labs reveal pancytopenia, marked transaminitis, extreme hyperferritinemia (>20,000 ng/mL), and hypofibrinogenemia (<150 mg/dL).
To differentiate between typical postoperative bacterial sepsis and other systemic syndromes.
3
Integrate medical history with acute findings.
The background of Adult-Onset Still's disease combined with this specific lab pattern strongly indicates Macrophage Activation Syndrome (MAS).
Patients with rheumatologic conditions (AOSD, systemic JIA) are at high risk for MAS when exposed to physiologic triggers like major surgery or systemic infection.
4
Determine the optimal therapeutic intervention.
High-dose corticosteroids (e.g., intravenous methylprednisolone) are selected as the first-line therapy.
Prompt immunosuppression is critical for survival in MAS to suppress the massive cytokine storm and macrophage proliferation.

Anahtar Kavram

Macrophage Activation Syndrome (MAS) is a life-threatening complication of rheumatologic conditions like Adult-Onset Still's disease, presenting with fever, hepatosplenomegaly, cytopenias, massive hyperferritinemia, and hypofibrinogenemia. It requires immediate treatment with high-dose corticosteroids.

Alternatif Yöntem

In cases where MAS is refractory to high-dose corticosteroids, subsequent steps often include cyclosporine, anakinra (IL-1 inhibitor), or etoposide based on standard HLH protocols.
Tahmini Süre:2m 0s
Bu soruyu puanla